Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Post Holdings
POST
$4.14B
| $89.4M | 0.08% |
1,313,163
-275,957
| -17% | -$19.4M |
|
302
Seagate
STX
$185B
| $89.2M | 0.08% |
1,893,201
+152,200
| +9% | +$7.08M |
|
303
Western Union
WU
$2.55B
| $89.2M | 0.08% |
4,484,376
+684,076
| +18% | +$13.3M |
|
304
Alkermes
ALKS
$8.79B
| $89M | 0.08% |
3,950,586
+2,302,600
| +140% | +$63.1M |
|
305
Lam Research
LRCX
$365B
| $88.7M | 0.08% |
4,720,710
-739,100
| -14% | -$14M |
|
306
Medifast
MED
$110M
| $88.6M | 0.08% |
690,315
-160,085
| -19% | -$22.2M |
|
|
VGR
307
DELISTED
Vector Group Ltd.
VGR
| $88.5M | 0.08% |
13,445,121
-403,288
| -3% | -$2.69M |
|
308
Sea Limited
SE
$63.9B
| $87.1M | 0.08% |
2,623,400
-555,529
| -17% | -$15.1M |
|
309
Chemed
CHE
$6.76B
| $86.5M | 0.08% |
239,598
-30,402
| -11% | -$10.2M |
|
310
Televisa
TV
$1.48B
| $86.3M | 0.08% |
10,230,986
+1,998,461
| +24% | +$19.5M |
|
311
Coca-Cola Femsa
KOF
$22.9B
| $86.3M | 0.08% |
1,389,200
+74,100
| +6% | +$4.75M |
|
312
Acuity Brands
AYI
$10.1B
| $86.1M | 0.08% |
624,600
+282,700
| +83% | +$38.9M |
|
313
Artisan Partners
APAM
$2.86B
| $84.3M | 0.07% |
3,063,415
+720,503
| +31% | +$19.2M |
|
314
RTX Corp
RTX
$294B
| $84M | 0.07% |
+1,025,237
| New | +$85.7M |
|
315
Trip.com Group
TCOM
$28.2B
| $83.8M | 0.07% |
2,269,800
-667,400
| -23% | -$26.3M |
|
316
Perdoceo Education
PRDO
$1.99B
| $83.4M | 0.07% |
4,374,762
+279,486
| +7% | +$5.16M |
|
317
MGIC Investment
MTG
$6.34B
| $83.3M | 0.07% |
6,338,100
+250,200
| +4% | +$3.48M |
|
318
Cheniere Energy
LNG
$53.6B
| $83.1M | 0.07% |
1,213,440
-862,600
| -42% | -$57.1M |
|
|
AVTA
319
DELISTED
Avantax, Inc. Common Stock
AVTA
| $83M | 0.07% |
2,733,300
+54,600
| +2% | +$1.8M |
|
320
Suncor Energy
SU
$75.6B
| $82.7M | 0.07% |
2,651,246
+1,552,600
| +141% | +$49.7M |
|
321
Kearny Financial
KRNY
$595M
| $82.5M | 0.07% |
6,205,363
+203,770
| +3% | +$2.74M |
|
322
Brookdale Senior Living
BKD
$3.69B
| $82.1M | 0.07% |
11,384,695
+4,022,079
| +55% | +$26.5M |
|
323
Highwoods Properties
HIW
$3.73B
| $81.3M | 0.07% |
1,968,400
-36,500
| -2% | -$1.62M |
|
|
AMTD
324
DELISTED
TD Ameritrade Holding Corp
AMTD
| $81.1M | 0.07% |
1,624,326
+1,140,400
| +236% | +$59.1M |
|
325
CoreCivic
CXW
$3.09B
| $80.7M | 0.07% |
3,885,300
+908,200
| +31% | +$19.5M |
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 495 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.